AU Patent

AU2024233006A1 — Microsphere formulations and methods of preparation thereof

Assigned to Lotus Biopharma Inc · Expires 2025-08-28 · 1y expired

What this patent protects

This disclosure provides injectable microsphere formulations capable of controlled long-term sustained release. The disclosed microsphere formulations demonstrate a zero-order release of active agents over a predetermined period of time. Also disclosed are methods of preparing th…

USPTO Abstract

This disclosure provides injectable microsphere formulations capable of controlled long-term sustained release. The disclosed microsphere formulations demonstrate a zero-order release of active agents over a predetermined period of time. Also disclosed are methods of preparing the microsphere formulations and methods of use thereof. The disclosed methods can be readily scaled up while maintaining a high drug encapsulation efficiency.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024233006A1
Jurisdiction
AU
Classification
Expires
2025-08-28
Drug substance claim
No
Drug product claim
No
Assignee
Lotus Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.